SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
Amendment No. 1
REPROS THERAPEUTICS INC.
--------------------------------------------------------------------------------
(Name of Issuer)
--------------------------------------------------------------------------------
(Title of Class of Securities)
76028H100
--------------------------------------------------------------------------------
(CUSIP Number)
DECEMBER 31, 2006
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 76028H100 13G Page 2 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Partners, L.P.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 75,032
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 75,032
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
75,032
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.74%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 76028H100 13G Page 3 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Partners II, L.P.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 3,714
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 3,714
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,714
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.04%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 76028H100 13G Page 4 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Offshore Fund, Ltd.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 11,750
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 11,750
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,750
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.12%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 76028H100 13G Page 5 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Offshore Fund II, Ltd.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 226,076
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 226,076
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
226,076
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.23%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 76028H100 13G Page 6 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Asset Management, L.L.C.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 78,746
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 78,746
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
78,746
(Reporting person disclaims beneficial ownership of shares held by ProMed
Partners, L.P. and ProMed Partners II, L.P. which represent the interests of
other partners of these entities.)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.78%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 76028H100 13G Page 7 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Management, Inc.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 237,826
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 237,826
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
237,826
(Reporting person disclaims beneficial ownership of shares held by ProMed
Offshore Fund, Ltd. and ProMed OffShore Fund II, Ltd. which represent the
interests of the shareholders of ProMed Offshore Fund, Ltd. and ProMed Offshore
Fund II, Ltd.)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.35%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 76028H100 13G Page 8 of 13 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Barry Kurokawa
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 30,000
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 316,572
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 30,000
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 316,572
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
346,572
(Reporting person disclaims beneficial ownership of shares held by ProMed
Offshore Fund, Ltd. and ProMed OffShore Fund II, Ltd. which represent the
interests of the shareholders of ProMed Offshore Fund, Ltd. and ProMed Offshore
Fund II, Ltd.)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.41%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 9 of 13 Pages
Item 1(a). Name of Issuer:
Repros Therapeutics
--------------------------------------------------------------------------------
Item 1(b). Address of Issuer's Principal Executive Offices:
2408 Timberloch Place, Suite B-1, Woodlands, TX 77380
--------------------------------------------------------------------------------
Item 2(a). Name of Person Filing:
ProMed Partners, L.P., ProMed Partners II, L.P., ProMed Offshore Fund, Ltd.,
ProMed OffShore Fund II, Ltd., ProMed Management, Inc., and ProMed Asset
Management, L.L.C., and Barry Kurokawa
--------------------------------------------------------------------------------
Item 2(b). Address of Principal Business Office, or if None, Residence:
125 Cambridgepark Drive, Cambridge, MA 02140
--------------------------------------------------------------------------------
Item 2(c). Citizenship:
See pages 2,3,4,5,6,7 and 8
--------------------------------------------------------------------------------
Item 2(d). Title of Class of Securities:
Common Stock
--------------------------------------------------------------------------------
Item 2(e). CUSIP Number:
76028H100
--------------------------------------------------------------------------------
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
(a) |_| Broker or dealer registered under Section 15 of the Exchange Act.
(b) |_| Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) |_| Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) |_| Investment company registered under Section 8 of the Investment
Company Act.
(e) |_| An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) |_| A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) |_| A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box |X|
Page 10 of 13 Pages
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
See pages 2,3,4,5,6,7 and 8
(b) Percent of class:
See pages 2,3,4,5,6,7 and 8
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
See pages 2,3,4,5,6,7 and 8
(ii) Shared power to vote or to direct the vote
See pages 2,3,4,5,6,7 and 8
(iii) Sole power to dispose or to direct the disposition of
See pages 2,3,4,5,6,7 and 8
(iv) Shared power to dispose or to direct the disposition of
See pages 2,3,4,5,6,7 and 8
--------------------------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
--------------------------------------------------------------------------------
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not Applicable
--------------------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Not Applicable
--------------------------------------------------------------------------------
Item 8. Identification and Classification of Members of the Group.
See "Exhibit A" attached hereto and pages 2, 3, 4, 5, 6, 7 and 8
--------------------------------------------------------------------------------
Item 9. Notice of Dissolution of Group.
Not Applicable
--------------------------------------------------------------------------------
Item 10. Certifications.
(a) The following certification shall be included if the statement is
filed pursuant to Rule 13d-1(b):
"By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held in
the ordinary course of business and were not acquired and not held for
the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction
having such purpose or effect."
(b) The following certification shall be included if the statement is
filed pursuant to Rule 13d-1(c):
"By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having such purpose or effect."
Page 11 of 13 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 6, 2007
----------------------------------------
(Date)
/s/ David B. Musket
----------------------------------------
(Signature)
David B. Musket,
President of Managing Member
of the General Partner
----------------------------------------
(Name/Title)
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
Schedule 13 G Page 12 of 13
CUSIP No. 76028H100
Index to Exhibits
Exhibit Page No.
------- --------
Exhibit A -- Joint Filing Agreement, dated February 6, 2007 12
Schedule 13 G Page 13 of 13
CUSIP No. 76028H100
EXHIBIT A
JOINT FILING AGREEMENT
ProMed Partners, L.P., ProMed Partners II, L.P., ProMed Offshore Fund, Ltd.,
ProMed Offshore Fund II, Ltd. ProMed Management, Inc., ProMed Asset Management,
LLC and Barry Kurokawa, each hereby agrees that the Schedule 13G to which this
Exhibit is attached and any amendments thereto relating to the acquisition of
Shares of Common Stock of Repros Therapeutics is filed jointly on behalf of each
such person.
Dated: February 6, 2007
PROMED PARTNERS, L.P.
By: ProMed Asset Management, LLC
its General Partner
By: DBM Corporate Consulting Group, Ltd,
a Managing Member
By: /s/ David B. Musket
--------------------------------------
David B. Musket
Director
PROMED PARTNERS, II, L.P.
By: ProMed Asset Management, LLC
its General Partner
By: DBM Corporate Consulting Group, Ltd.
a Managing Member
By: /s/ David B. Musket
--------------------------------------
David B. Musket
Director
PROMED OFFSHORE FUND, LTD.
By: /s/ David B. Musket
--------------------------------------
David B. Musket
Director
PROMED OFFSHORE FUND II, LTD.
By: /s/ David B. Musket
--------------------------------------
David B. Musket
Director
PROMED MANAGEMENT, INC.
By: /s/ David B. Musket
--------------------------------------
David B. Musket
President
PROMED ASSET MANAGEMENT, LLC
By: DBM Corporate Consulting Group, Ltd.
A Managing Member
By: /s/ David B. Musket
--------------------------------------
David B. Musket
President
Barry Kurokawa
By: /s/ Barry Kurokawa
--------------------------------------